Indivior Plc
INDV
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.84B
Close$
$-1.25
103.3% downside
Current Fair Value
103.3% downsideOvervalued by 103.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.84 Billion |
|---|---|
| Enterprise Value | $4.73 Billion |
| Dividend Yield | $0.64 (-) |
| Earnings per Share | $1.68 |
| Beta | 1.03 |
| Outstanding Shares | 125,352,000 |
Return
| Return on Equity | -175.00% |
|---|---|
| Return on Assets | 21.05% |
| Return on Invested Capital | 81.10% |
Valuation & Multiples
| P/E Ratio | 13.67 |
|---|---|
| PEG | 15.3 |
| Price to Sales | 3.82 |
| Price to Book Ratio | -19.11 |
| Enterprise Value to Revenue | 3.67 |
| Enterprise Value to EBIT | 13.96 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.44 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.89
Average shareholder expectationRevenue Estimate
$307.55 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$1.06
Average shareholder expectationRevenue Estimate
$329.35 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 87.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 27.17%▼ 75.01% |
|---|---|
| Total Invested | $1.40B▼ 64.09% |
| Investors Holding | 132▼ 164.00% |
ESG Score
No data
About Indivior Plc
CEO: Shaun Thaxter Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, ...